Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)
Clinical trial NCT04623099 · RECRUITING
Trial details
- NCT number
- NCT04623099
- Sponsor
- University of Cincinnati
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2026-06-30
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.